Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tanner Pharma Group is a global specialty pharmaceutical services company that provides comprehensive solutions to improve patient access to medicines. The company's TannerGAP (Global Access Program) division specializes in the implementation of managed access programs, expanded access, and compassionate use, facilitating the distribution of medicines to patients in regions where they are not yet commercially available. In addition to global access, Tanner offers clinical trial supply services (TannerCTS) and commercial distribution in Latin America (TannerLAC). Headquartered in the United States with a global presence, the firm partners with pharmaceutical and biotech companies to navigate complex regulatory environments and reach underserved markets. Their services are critical for manufacturers looking to provide treatments for rare diseases or life-threatening conditions before full market authorization is achieved.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TannerGAP.